|
Concentrations
Juvederm
18
When
injected into the superficial dermis, the fluid version,
Juvederm 18, fills fine wrinkles such as crow's feet or
peri-oral wrinkles.
Juvederm
24
When
injected into the middle dermis, the dense version, Juvederm
24, effectively fills forehead wrinkles, glabellar lines,
obvious mild to moderate nasal furrows and cheek wrinkles.
Juvederm
30
When
injected into the deep dermis, the densest version, Juvederm
30, fills deep naso-genian folds, returns volume to your
lips, sculptures your cheeks and gives your face, its natural
oval shape again.
Treated
areas should be gently massaged immediately after injection
in order to check that the product is evenly distributed.
A follow-up procedure a few weeks after the initial treatment
is recommended to optimize the outcome.
|
 |
RENOVA®
(tretinoin emollient cream) 0.05% is the first prescription
cream proven to reduce fine facial wrinkles and lines,
fade brown spots and smooth surface roughness when
used as part of a total skin care and sun protection
program.
RENOVA
contains the same active ingredient as RETIN-A®
(tretinoin). Called tretinoin, it is a vitamin A derivative
like the one naturally occurring in your body. But
while RETIN-A is formulated for acne-prone skin, RENOVA
is a rich emollient cream developed specifically for
treating fine lines and wrinkles, brown spots and
surface roughness.
|
Unlike
over-the-counter wrinkle creams which simply exfoliate the
surface layer of skin, RENOVA is believed to work on all
layers of the skin, including the epidermis, where pigmentary
changes occur and even the deeper portions of the skin where
fine wrinkling is thought to begin.
Medical
research has shown in published articles that RENOVA increases
collagen.
Researchers
believe this is one way that RENOVA reduces the signs of
aging. Patients who respond to RENOVA will begin to notice
their skin becoming smoother and softer within the first
month or two. Within two to three months, brown spots, fine
lines and wrinkles begin to fade. Maximum benefits should
be apparent within five to six months of therapy. More than
300 patients between the ages of 30 and 50 participated
in the pivotal clinical studies of RENOVA, which were conducted
at eight research centers nationwide. In the studies, patients
received treatment with RENOVA or a placebo, in conjunction
with a total skin care and sun protection program. At the
end of 24 weeks, physicians noted some signs of skin improvement
in 78 percent of patients treated with RENOVA.
While
using RENOVA, patients may experience some redness, itching,
dryness, or flaking. This is most often mild, and most common
when treatment is started. When using RENOVA, as with any
other anti-aging or skin-care product, patients should limit
exposure to the sun and always use a sunscreen.
Like
other prescription medications, RENOVA has been tested for
safety and effectiveness. While it will not repair sun damaged
skin, eliminate wrinkles, or reverse the aging process,
it is proven to reduce wrinkles, fade brown spots and smooth
surface roughness.
RENOVA
has been proven effective in clinical trials lasting 48
weeks in Caucasians 30 to 50 years old. RENOVA is a dermal
irritant, and the results of continued irritation for greater
than 48 weeks are not known, safety and effectiveness in
individuals over 50 or in those with moderately or heavily
pigmented skin have not been established.
|